With respect to assay development, quality assurance and, ultimately, clinical adoption, the primary subject of this review, these advantages are critical. Implicit with these advantages, TMAs enable ...

Abstract: Tissue Microarrays (TMA) is a kind of high-throughput, cost-effective and rapid method for testing or analyzing tissue specimens like clinical biopsies and tumor samples. However, the ...

TORONTO, Nov. 25 /CNW/ - SQI Diagnostics Inc. (TSX-Venture: SQD), a medical systems automation company focused on evolving laboratory-based biomarker testing, announced today that Health Canada has ...